Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Important Advances in Oncology
1991559 citationsVincent T. DeVita, S Hellman et al.Anti-Cancer Drugsprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of S Hellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Hellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Hellman more than expected).
This network shows the impact of papers produced by S Hellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Hellman. The network helps show where S Hellman may publish in the future.
Co-authorship network of co-authors of S Hellman
This figure shows the co-authorship network connecting the top 25 collaborators of S Hellman.
A scholar is included among the top collaborators of S Hellman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Hellman. S Hellman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Vijayakumar, Srinivasan, R Weichselbaum, Florin Vaida, William Dale, & S Hellman. (2006). Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.. PubMed. 2(4). 225–33.11 indexed citations
Al‐Hallaq, Hania, et al.. (2006). 1086. International Journal of Radiation Oncology*Biology*Physics. 66(3). S179–S180.3 indexed citations
5.
Heimann, Ruth, et al.. (2000). Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.. PubMed. 60(2). 298–304.141 indexed citations
6.
Vijayakumar, Srinivasan, Florin Vaida, R Weichselbaum, & S Hellman. (1998). Race and the Will Rogers phenomenon in prostate cancer.. PubMed. 4(1). 27–34.29 indexed citations
Hellman, S, et al.. (1997). Effect of ethnicity on adherence to diabetic regimen.. PubMed. 7(3). 221–8.10 indexed citations
9.
Hellman, S & L. E. Baker. (1997). A new use for focus groups--building and empowering a culturally diverse team.. PubMed. 1(6). 297–300.2 indexed citations
Jeevanandam, Valluvan, et al.. (1994). Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.. PubMed. 13(4). 681–7; discussion 685.64 indexed citations
14.
DeVita, V. T., et al.. (1992). Biologic Therapy of Cancer. Histopathology. 20(3). 278–278.382 indexed citations
15.
DeVita, Vincent T., S Hellman, & S A Rosenberg. (1991). Important Advances in Oncology. Anti-Cancer Drugs. 2(4). 419–419.559 indexed citations breakdown →
Mauch, P, Dov Gorshein, Joan Cunningham, & S Hellman. (1982). Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.. PubMed. 66(4). 809–17.64 indexed citations
18.
Hellman, S, Jeffrey R. Harris, & Martin B. Levene. (1980). Radiation therapy of early carcinoma of the breast without mastectomy. [Linear acceleraor and iridium implants]. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).1 indexed citations
19.
Chaffey, John T., S Hellman, Donald Rosenthal, & William C. Moloney. (1977). Total-body irradiation in the treatment of lymphocytic lymphoma.. PubMed. 61(6). 1149–52.20 indexed citations
20.
Hellman, S, et al.. (1973). Invited discussion: Laparotomy alters treatment in Hodgkin's disease.. PubMed. 36. 307–11.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.